Holdings

BIOS Capital Management, LP

As of Sep 30, 2026, BIOS Capital Management, LP reported 6 positions worth US$34.2M. Largest: Opus Genetics, Inc., Actuate Therapeutics, Inc. and Cognition Therapeutics, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Opus Genetics, Inc.3.68MUS$17.8Mno changeSep 30, 2026
Actuate Therapeutics, Inc.10MUS$7.84Mno changeSep 30, 2026
Cognition Therapeutics, Inc.6MUS$5.76Mno changeSep 30, 2026
Rein Therapeutics, Inc.2.98MUS$2.4Mno changeSep 30, 2026
Lantern Pharma Inc.236KUS$238K−13,502Sep 30, 2026
IN8bio, Inc.80,957US$108Kno changeSep 30, 2026